SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2022 / Cilt: 50 - Sayı: 5

The Role of Prophylactic Ipsilateral Distal Femoral Artery Cannulation in Preventing Periprocedural Peripheral Complications During Transcatheter Aortic Valve Implantation

Can Yücel KARABAY
Gönül ZEREN
Şahin YILMAZZ
Barış ŞİMŞEK
Mehmet Fatih YILMAZ
İlhan İlker AVCI
Mustafa Azmi SUNGUR
Fatma CAN
Ufuk GÜRKAN
Pages
327–333
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Prophylactic cannulation of the ipsilateral distal femoral artery is a simple, effective, and safe method in the management of access site-related vascular complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Access site-related vascular complications are common complications of transcatheter aortic valve replacement.
📊
Key Findings & Data:Methods: One hundred sixty-four patients, who were evaluated by the Heart Team of our institution and found eligible for transcatheter aortic valve replacement procedure between January 2016 and August 2019, were included in this retrospective study.
💡
Conclusion & Impact:Conclusion: Prophylactic cannulation of the ipsilateral distal femoral artery is a simple, effective, and safe method in the management of access site-related vascular complications.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Access site-related vascular complications are common complications of transcatheter aortic valve replacement. In this study, we aimed to investigate the efficacy and safety of prophylactic cannulation of the ipsilateral distal femoral artery in the management of access site-related vascular complications. Methods: One hundred sixty-four patients, who were evaluated by the Heart Team of our institution and found eligible for transcatheter aortic valve replacement procedure between January 2016 and August 2019, were included in this retrospective study. Patients were divided into two groups according to the management of peripheral complications. The antegrade crossover was used as bailout treatment in the first 70 patients. Prophylactic cannulation of the ipsilateral distal femoral artery was performed in the last 94 patients. These 2 groups were compared. Results: Peripheral complications developed in 15 of the first 70 patients included in the study. The percutaneous intervention was unsuccessful in 4 of the patients who underwent bailout antegrade crossover. Peripheral complications developed in 14 of the last 94 patients in whom prophylactic cannulation of the ipsilateral distal femoral artery was performed, and all these patients were managed successfully with percutaneous intervention. Conclusion: Prophylactic cannulation of the ipsilateral distal femoral artery is a simple, effective, and safe method in the management of access site-related vascular complications.

🔖

Cite This Article

KARABAY, C. Y., ZEREN, G., YILMAZZ, Ş., ŞİMŞEK, B., YILMAZ, M. F., AVCI, İ. İ., SUNGUR, M. A., CAN, F., GÜRKAN, U. (2022). The Role of Prophylactic Ipsilateral Distal Femoral Artery Cannulation in Preventing Periprocedural Peripheral Complications During Transcatheter Aortic Valve Implantation. Türk Kardiyoloji Derneği Arşivi, Cilt: 50 - Sayı: 5, 327–333. https://ajindex.com/articles/631790

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter vs. surgicalaortic valve replacement in high risk patients. N Engl J Med. 2011
  2. 364(23):2187-2198. [CrossRef] 2. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010
  3. 363(17):1597-1607. [CrossRef] 3. Gurvitch R, Toggweiler S, Willson AB, et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention. 2011
  4. 7(1):41-48. [CrossRef] 4. Stähli BE, Bünzli R, Grünenfelder J, et al. Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC). J Invasive Cardiol. 2011
  5. 23(8):307-312. 5. Nuis RJ, Piazza N, Van Mieghem NM, et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions. Catheter Cardiovasc Interv. 2011
  6. 78(3):457-467. [CrossRef] 6. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011
  7. 4(8):851-858. [CrossRef] 7. Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012
  8. 59(25):2317- 2326. [CrossRef] 8. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012
  9. 366(18):1686-1695. [CrossRef] 9. Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. J Am Coll Cardiol Intv. 2011
  10. 4(7):743-750. [CrossRef] 10. Eltchaninoff H, Durand E, Borz B, et al. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards Sapien XT versus SAPIEN prostheses. Arch Cardiovasc Dis. 2012
  11. 105(3):132-140. [CrossRef] 11. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012
  12. 59(2):113-118. [CrossRef] 12. Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence